The Technology Strategy Board (TSB) has announced the nine winners of the 2007 Cell Therapy funding competition. Neotherix is part of a consortium developing the RegeniTherix wound treatment and monitoring system, which has been awarded £570k of the £6.3m awarded overall. The project started in July 2008.
Other consortium partners are Complement Genomics Ltd, the National Physical Laboratory, and SensaPharm Ltd (previously Cord8 Ltd).
This item updates our previous news item announcing our successful application for this funding. More details on the RegeniTherix project will be available in the Neotherix press release, to be published shortly.
Links to full TSB press release , Complement Genomics Ltd , SensaPharm Ltd and National Physical Laboratory